SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-006692
Filing Date
2022-02-24
Accepted
2022-02-24 16:06:19
Documents
13
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sdgr-8k_20220224.htm   iXBRL 8-K 44181
2 EX-99.1 sdgr-ex991_6.htm EX-99.1 780357
  Complete submission text file 0001564590-22-006692.txt   984070

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sdgr-20220224.xsd EX-101.SCH 5705
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20220224_lab.xml EX-101.LAB 19435
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20220224_pre.xml EX-101.PRE 11595
7 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-8k_20220224_htm.xml XML 3540
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 22670906
SIC: 2834 Pharmaceutical Preparations